Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FTGXQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,602
Award facts
- Contract value 100% obligated
- $34,601.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,601.94 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injector pharmaceutical product. The delivery order, which carries an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The award was competitively made with no set-aside designation applied.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the product delivery at its corporate office location in the same city. The company functions as a critical vendor for federal medical procurement, providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. ENBREL, an immunosuppressant therapeutic agent, is representative of the specialized pharmaceutical products that AmerisourceBergen routinely delivers through its DLA contracts to support military medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FTGXQ?
SPE2DB25FTGXQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FTGXQ worth?
The government has obligated $34,602 on SPE2DB25FTGXQ.
Is contract SPE2DB25FTGXQ an order under another contract?
Yes. SPE2DB25FTGXQ is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGXQ competed?
The extent of competition for SPE2DB25FTGXQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award